Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease
NCT04603729
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Covid 19 Disease
Interventions
DRUG:
Dexamethasone 2 MG/ML
DRUG:
Methylprednisolone Injection
Sponsor
Fatima Memorial Hospital